1041 studies found for:    cancer | wake forest
Show Display Options
Rank Status Study
21 Completed
Has Results
Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
Conditions: Childhood Hepatocellular Carcinoma;   Papillary Thyroid Cancer;   Previously Treated Childhood Rhabdomyosarcoma;   Recurrent Childhood Liver Cancer;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Thyroid Cancer;   Recurrent Wilms Tumor and Other Childhood Kidney Tumors
Interventions: Drug: sorafenib tosylate;   Other: pharmacological study;   Other: laboratory biomarker analysis
22 Completed
Has Results
Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Biological: filgrastim;   Biological: pegfilgrastim;   Drug: docetaxel;   Drug: trabectedin
23 Unknown  Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
Conditions: Fallopian Tube Cancer;   Ovarian Cancer
Interventions: Genetic: proteomic profiling;   Other: surface-enhanced laser desorption/ionization-time of flight mass spectrometry;   Procedure: biopsy
24 Recruiting Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer
Condition: Rectal Cancer
Interventions: Drug: CRLX101;   Drug: Capecitabine;   Radiation: Radiotherapy;   Procedure: Surgery
25 Terminated
Has Results
Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases
Conditions: Metastatic Cancer;   Prostate Cancer
Interventions: Drug: paricalcitol;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis;   Procedure: dual x-ray absorptometry;   Procedure: quality-of-life assessment
26 Active, not recruiting Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: docetaxel;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Procedure: adjuvant therapy;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
27 Active, not recruiting Stress and Coping in Caregivers of Younger Patients With Cancer
Conditions: Anxiety;   Depression
Interventions: Other: Laboratory Biomarker Analysis;   Other: Physiologic Testing;   Other: Questionnaire Administration
28 Completed Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer
Conditions: Limited Stage Small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IA Non-small Cell Lung Cancer;   Stage IB Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Tobacco Use Disorder
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Other: counseling intervention;   Other: internet-based intervention;   Behavioral: telephone-based intervention;   Other: educational intervention;   Drug: nicotine replacement therapy
29 Active, not recruiting Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: LHRH agonist;   Procedure: surgery
30 Completed
Has Results
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking
Conditions: Breast Cancer;   Colorectal Cancer;   Lung Cancer;   Prostate Cancer;   Tobacco Use Disorder
Interventions: Drug: memantine hydrochloride;   Drug: placebo
31 Active, not recruiting Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Conditions: Estrogen Receptor Negative;   Estrogen Receptor Positive;   HER2/Neu Negative;   Male Breast Carcinoma;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Biological: Bevacizumab;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Placebo;   Other: Quality-of-Life Assessment
32 Completed
Has Results
Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer
Conditions: Carcinoma of the Appendix;   Colorectal Cancer
Interventions: Drug: thalidomide;   Procedure: surgery
33 Recruiting Study of Kidney Tumors in Younger Patients
Conditions: Clear Cell Sarcoma of the Kidney;   Congenital Mesoblastic Nephroma;   Diffuse Hyperplastic Perilobar Nephroblastomatosis;   Rhabdoid Tumor of the Kidney;   Stage I Renal Cell Cancer;   Stage I Wilms Tumor;   Stage II Renal Cell Cancer;   Stage II Wilms Tumor;   Stage III Renal Cell Cancer;   Stage III Wilms Tumor;   Stage IV Renal Cell Cancer;   Stage IV Wilms Tumor;   Stage V Wilms Tumor
Interventions: Other: laboratory biomarker analysis;   Other: cytology specimen collection procedure
34 Completed
Has Results
Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer
Conditions: Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Procedure: CT;   Drug: 18F-FLT;   Procedure: PET
35 Terminated
Has Results
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Other: placebo;   Drug: selenium
36 Terminated Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Condition: Breast Cancer
Interventions: Drug: tamoxifen citrate;   Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis
37 Recruiting Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: radiation therapy;   Radiation: Whole-pelvic radiotherapy (WPRT)
38 Active, not recruiting Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
Conditions: Stage I Ovarian Cancer;   Stage IA Fallopian Tube Cancer;   Stage IB Fallopian Tube Cancer;   Stage IC Fallopian Tube Cancer;   Stage II Ovarian Cancer;   Stage IIA Fallopian Tube Cancer;   Stage IIB Fallopian Tube Cancer;   Stage IIC Fallopian Tube Cancer;   Stage III Ovarian Cancer;   Stage III Primary Peritoneal Cancer;   Stage IIIA Fallopian Tube Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Cancer;   Stage IV Primary Peritoneal Cancer
Interventions: Procedure: Assessment of Therapy Complications;   Drug: Carboplatin;   Biological: Filgrastim;   Drug: Paclitaxel;   Other: Pharmacological Study;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
39 Recruiting Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Biological: cetuximab;   Radiation: intensity-modulated radiation therapy
40 Unknown  Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
Conditions: Chronic Myeloproliferative Disorders;   Kidney Cancer;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Biological: anti-thymocyte globulin;   Biological: filgrastim;   Biological: graft-versus-tumor induction therapy;   Biological: therapeutic allogeneic lymphocytes;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Drug: methotrexate;   Drug: mycophenolate mofetil;   Drug: tacrolimus;   Procedure: allogeneic bone marrow transplantation;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years